Skip to main content

and
  1. Article

    Open Access

    KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway

    Multiple myeloma (MM) is an incurable hematological malignancy characterized by clonal proliferation of malignant plasma B cells in bone marrow, and its pathogenesis remains unknown. The aim of this study was ...

    Meng Zhai, Jiyu Miao, Ru Zhang, Rui Liu in Journal of Cancer Research and Clinical On… (2024)

  2. Article

    Open Access

    Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia

    Acute myeloid leukemia (AML) is a hematological malignancy derived from the accumulation of abnormal proliferation of infantile leukocytes in the hematopoietic system. DNA-damage-inducible transcript 4 (DDIT4) ac...

    Fangmei Li, Jiyu Miao, Rui Liu, Ru Zhang in Journal of Cancer Research and Clinical On… (2024)

  3. No Access

    Article

    Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression

    N6-methyladenosine (m6A) is the most abundant RNA modification. M6A RNA methylation is reversible: m6A is installed by “writers”, removed by “erasers”, and recognized by “readers”. Readers are executors to regula...

    Rui Liu, Yachun Jia, Guangyao Kong, Aili He in Journal of Cancer Research and Clinical On… (2022)

  4. No Access

    Article

    Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia

    MLAA-34 is a newly identified monocytic leukemia-associated antigen. Previous data indicated that MLAA-34 might be a novel anti-apoptosis factor related closely to carcinogenesis or progression of acute monocy...

    Jianqiang Zhao, Aili He, Wanggang Zhang, **n Meng in Cancer Immunology, Immunotherapy (2011)